Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the Q3 2024 Vanda Pharmaceuticals Inc. Earnings Conference Call.
Vanda Pharmaceuticals Inc. (VNDA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 4,011,522 | $18,814,038 | -3% | 0.02% |
| 2. | Tang Capital Management Kevin C. Tang | 2,353,307 | $11,037,010 | +10% | 0.78% |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,593,516 | $7,473,590 | 0.37% | |
| 4. | D E Shaw D. E. Shaw | 559,798 | $2,625,453 | -20% | 0% |
| 5. | Millennium Management Israel Englander | 399,510 | $1,873,702 | +2361% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.97 | 3,239 | Large Shareholder, Other | 1,103,617 | 2015-12-16 | Filing | |
| $8.97 | 4,441 | Large Shareholder, Other | 2,740,122 | 2015-12-16 | Filing | |
| $8.97 | 3,490 | Large Shareholder, Other | 2,152,952 | 2015-12-16 | Filing | |
| $8.61 | 93,634 | Large Shareholder, Other | 1,100,378 | 2015-12-11 | Filing | |
| $8.61 | 128,374 | Large Shareholder, Other | 2,735,681 | 2015-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.17 | 5,000 | 44,857 | 2024-11-14 | Filing | ||
| $5.92 | 2,251 | 228,763 | 2024-07-29 | Filing | ||
| $4.18 | 8,941 | 196,825 | 2024-03-05 | Filing | ||
| $4.41 | 8,147 | 205,766 | 2024-03-04 | Filing | ||
| $4.21 | 9,229 | 129,789 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,346,367 | $35,221,670 | 0% | |
| 2. | 3,456,087 | $14,584,687 | 0% | |
| 3. | 2,022,968 | $8,536,923 | 0% | |
| 4. | 1,967,985 | $8,305,054 | 0% | |
| 5. | 1,919,002 | $8,098,188 | 0% |
News See All
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Meg, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2024 Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Hermine, and I will be your conference operator today. At this time, I would like to welcome everyone to Q1 2024 Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2023 Vanda Pharmaceuticals Inc.
What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?
Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Cash-Rich Penny Stocks Hedge Funds Are Buying
This article presents an overview of the 5 Cash-Rich Penny Stocks Hedge Funds Are Buying. For a detailed overview of such stocks, read our article, 15 Cash-Rich Penny Stocks Hedge Funds Are Buying...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
15 Best Affordable Stocks To Buy Under $5
In this article, we discuss 15 best affordable stocks to buy under $5.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is David and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Q1 2023 Vanda Pharmaceuticals Inc.